JP2023022224A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023022224A5 JP2023022224A5 JP2022191728A JP2022191728A JP2023022224A5 JP 2023022224 A5 JP2023022224 A5 JP 2023022224A5 JP 2022191728 A JP2022191728 A JP 2022191728A JP 2022191728 A JP2022191728 A JP 2022191728A JP 2023022224 A5 JP2023022224 A5 JP 2023022224A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (1)
- 明細書に記載される発明。
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511889P | 2017-05-26 | 2017-05-26 | |
| US62/511,889 | 2017-05-26 | ||
| US15/859,279 US20180338922A1 (en) | 2017-05-26 | 2017-12-29 | Fixed dose formulations |
| US15/859,279 | 2017-12-29 | ||
| JP2019565302A JP7187488B2 (ja) | 2017-05-26 | 2018-05-25 | 固定用量製剤 |
| PCT/US2018/034646 WO2018218147A1 (en) | 2017-05-26 | 2018-05-25 | Fixed dose formulations |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565302A Division JP7187488B2 (ja) | 2017-05-26 | 2018-05-25 | 固定用量製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023022224A JP2023022224A (ja) | 2023-02-14 |
| JP2023022224A5 true JP2023022224A5 (ja) | 2023-04-10 |
| JP7561814B2 JP7561814B2 (ja) | 2024-10-04 |
Family
ID=62621055
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565302A Active JP7187488B2 (ja) | 2017-05-26 | 2018-05-25 | 固定用量製剤 |
| JP2022191728A Active JP7561814B2 (ja) | 2017-05-26 | 2022-11-30 | 固定用量製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565302A Active JP7187488B2 (ja) | 2017-05-26 | 2018-05-25 | 固定用量製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20180338922A1 (ja) |
| EP (1) | EP3630070A1 (ja) |
| JP (2) | JP7187488B2 (ja) |
| KR (2) | KR20240130156A (ja) |
| CN (1) | CN110996914A (ja) |
| AU (2) | AU2018272040A1 (ja) |
| BR (1) | BR112019024747A2 (ja) |
| CA (1) | CA3064895A1 (ja) |
| CL (1) | CL2019003437A1 (ja) |
| IL (1) | IL270866A (ja) |
| MX (2) | MX2019014122A (ja) |
| TW (2) | TW202400126A (ja) |
| UA (1) | UA126451C2 (ja) |
| WO (1) | WO2018218147A1 (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107530307A (zh) | 2015-03-13 | 2018-01-02 | 艾斯柏伦治疗公司 | 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法 |
| KR20200123181A (ko) * | 2018-02-16 | 2020-10-28 | 에스페리온 테라피유틱스 인코포레이티드 | 뱀페도익산의 지속 방출형 제제 |
| US20210322375A1 (en) * | 2018-08-27 | 2021-10-21 | Esperion Therapeutics, Inc. | Combination drug formulations for treating patients with cardiovascular disease and associated conditions |
| EP3666750A1 (en) * | 2018-12-10 | 2020-06-17 | Sandoz AG | Crystalline form of bempedoic acid |
| WO2020213010A1 (en) * | 2019-04-16 | 2020-10-22 | Celagenex Research (India) Pvt. Ltd. | Synergistic lipid controlling compositions |
| EP3986860A1 (en) | 2019-06-21 | 2022-04-27 | Esperion Therapeutics, Inc. | Salt forms of bempedoic acid and methods for using the same |
| CN114746389A (zh) | 2019-10-03 | 2022-07-12 | 斯索恩有限公司 | 贝派地酸的晶形 |
| EP4069668A1 (en) | 2019-12-06 | 2022-10-12 | Synthon B.V. | Crystalline forms of sodium salt of bempedoic acid |
| WO2021205887A1 (ja) * | 2020-04-10 | 2021-10-14 | 日本酢ビ・ポバール株式会社 | 徐放性基剤 |
| WO2021220236A1 (en) * | 2020-05-01 | 2021-11-04 | Cadila Healthcare Limited | Pharmaceutical compositions for combination therapy |
| CN111559961A (zh) * | 2020-05-26 | 2020-08-21 | 杭州科巢生物科技有限公司 | 一种贝派地酸晶型及其制备方法 |
| WO2021255180A1 (en) | 2020-06-19 | 2021-12-23 | Synthon B.V. | Salts of bempedoic acid |
| EP4401708A1 (en) | 2021-09-13 | 2024-07-24 | Synthon B.V. | Pharmaceutical composition of bempedoic acid |
| WO2023217694A1 (en) | 2022-05-09 | 2023-11-16 | Renata Pharmaceutical (Ireland) Ltd | Pharmaceutical composition of bempedoic acid |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| DE60216890T2 (de) | 2001-01-26 | 2007-08-30 | Schering Corp. | Kombinationen von einem hemmer der sterol-absorption und einem ppar-aktivator zur behandlung von kardiovaskulären indikationen |
| JP4438268B2 (ja) | 2001-03-07 | 2010-03-24 | 大日本住友製薬株式会社 | 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤 |
| US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| MXPA05007674A (es) | 2003-01-23 | 2005-09-22 | Esperion Therapeutics Inc | Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados. |
| AU2009292615B2 (en) * | 2008-09-17 | 2015-12-03 | Mylan Inc. | Granulates, process for preparing them and pharmaceutical products containing them |
| JO3239B1 (ar) * | 2008-09-22 | 2018-03-08 | Novartis Ag | تركيبات جالينية من مركبات عضوية |
| ES2382773T3 (es) * | 2009-03-13 | 2012-06-13 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Composiciones de ezetimiba |
| DK2407166T3 (da) * | 2009-03-13 | 2013-10-07 | Toyama Chemical Co Ltd | Tablet og granuleret pulver indeholdende 6-fluor-3-hydroxy-2-pyrazin-carboxamid |
| BR112012002069B8 (pt) | 2009-07-28 | 2021-05-25 | Egis Gyogyszergyar Nyilvanosan Muekodo Reszvenytarsasag | processo para a fabricação de um granulado contendo ezetimibe microcristalino |
| CN101926756B (zh) * | 2010-08-12 | 2012-01-18 | 北京赛科药业有限责任公司 | 一种氯吡格雷或其药学上可接受盐的固体制剂 |
| AR083417A1 (es) * | 2010-10-14 | 2013-02-21 | Novartis Ag | Composiciones farmaceuticas que contienen un dgat1 inhibidor |
| AR086675A1 (es) * | 2011-06-14 | 2014-01-15 | Merck Sharp & Dohme | Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa-4 con simvastatina |
| CN104023725B (zh) * | 2011-08-16 | 2019-04-26 | 卡迪欧拉有限公司 | 控释制剂 |
| CN105916598B (zh) * | 2014-01-21 | 2020-07-17 | Bpsi控股有限责任公司 | 含有中链甘油酯的即释型膜包衣及用其包被的基质 |
| CN107530307A (zh) | 2015-03-13 | 2018-01-02 | 艾斯柏伦治疗公司 | 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法 |
| MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
| WO2017023165A1 (en) * | 2015-08-04 | 2017-02-09 | Dezima Pharma B.V. | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and an atp citrate lyase inhibitor – ampk activator |
| CA3000016A1 (en) * | 2015-11-06 | 2017-05-11 | Gemphire Therapeutics Inc. | Gemcabene combinations for the treatment of cardiovascular disease |
-
2017
- 2017-12-29 US US15/859,279 patent/US20180338922A1/en not_active Abandoned
-
2018
- 2018-05-25 JP JP2019565302A patent/JP7187488B2/ja active Active
- 2018-05-25 BR BR112019024747A patent/BR112019024747A2/pt unknown
- 2018-05-25 EP EP18731684.9A patent/EP3630070A1/en active Pending
- 2018-05-25 WO PCT/US2018/034646 patent/WO2018218147A1/en active Application Filing
- 2018-05-25 MX MX2019014122A patent/MX2019014122A/es unknown
- 2018-05-25 TW TW112108490A patent/TW202400126A/zh unknown
- 2018-05-25 KR KR1020247028001A patent/KR20240130156A/ko not_active Application Discontinuation
- 2018-05-25 KR KR1020197038244A patent/KR102698987B1/ko active IP Right Grant
- 2018-05-25 TW TW107118013A patent/TWI798228B/zh active
- 2018-05-25 AU AU2018272040A patent/AU2018272040A1/en not_active Abandoned
- 2018-05-25 CA CA3064895A patent/CA3064895A1/en active Pending
- 2018-05-25 UA UAA201911462A patent/UA126451C2/uk unknown
- 2018-05-25 CN CN201880049937.4A patent/CN110996914A/zh active Pending
-
2019
- 2019-11-24 IL IL270866A patent/IL270866A/en unknown
- 2019-11-25 CL CL2019003437A patent/CL2019003437A1/es unknown
- 2019-11-26 MX MX2023006541A patent/MX2023006541A/es unknown
-
2022
- 2022-04-14 US US17/720,625 patent/US20220249380A1/en active Pending
- 2022-11-30 JP JP2022191728A patent/JP7561814B2/ja active Active
-
2024
- 2024-06-26 AU AU2024204369A patent/AU2024204369A1/en active Pending